StockData
Bone Biologics Corp logo

Bone Biologics Corp (BBLG) stock

BBLGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 6/30
$0.29−0.02 (-5.92%)

Close on Nov 18, 2026Market cap $986.22KP/E –Yield –

Bone Biologics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Bone Biologics's price to book ratio was 0.2× on Nov 11, 2026, against 0.4× a year earlier. Over the last 5 years it ranged from 0.2× to 26.3×, with a median of 2.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.2×−0.3
2025Dec 31, 20250.4×−2.7
2024Dec 31, 20243.1×+0.3
2023Dec 29, 20232.8×+0.5
2022Dec 30, 20222.3×–

More Bone Biologics figures

See a number that looks wrong?